U.S. Packaging Stock News

Byline Bancorp (BY) has put up a solid Q1 2026 print, with revenue at US$106.9 million and basic EPS of US$0.84, supported by trailing 12 month revenue of US$422.9 million and EPS of US$3.09 that keep the earnings trend in focus. Over recent quarters, revenue has moved from US$93.9 million in Q1 2025 to US$106.9 million in Q1 2026, while basic EPS has shifted from US$0.65 to US$0.84, giving you a clear picture of how the top and bottom line are tracking into the new year. With a trailing net...

Kinsale Capital Group (KNSL) opened 2026 with Q1 revenue of US$466.7 million and basic EPS of US$4.90, setting the tone for how its specialty insurance book is currently feeding through to the bottom line. Over the past year, the company has seen trailing twelve month revenue move from US$1.64 billion to US$1.92 billion, while basic EPS over the same trailing period shifted from US$17.49 to US$22.82. This gives investors a clear view of how top line and per share earnings have tracked...

Hexcel (HXL) opened Q1 2026 with revenue of US$501.5 million and basic EPS of US$0.49, setting the tone for how investors are reading the new earnings season. The company has seen quarterly revenue range from US$456.5 million in Q1 2025 to US$491.3 million in Q4 2025, while basic EPS moved between US$0.17 in Q2 2025 and US$0.60 in Q4 2025. This gives a clear view of how the top and bottom lines have tracked into this latest print. With that backdrop, the key question now is whether current...

AptarGroup (NYSE:ATR) has been recognized as one of America’s Climate Leaders for the fourth consecutive year by USA Today. The latest recognition highlights the company’s ongoing efforts around emissions reductions and broader sustainability goals. Repeat accolades from USA Today and the CDP continue to validate AptarGroup’s climate focused initiatives. AptarGroup, trading at around $124.94 per share, is drawing attention for its sustainability profile as much as its role in dispensing and...

Dime Community Bancshares (DCOM) Q1 2026 results in focus Dime Community Bancshares (DCOM) has just reported its Q1 2026 results with recent quarterly revenue most recently at about US$112.9 million in Q4 2025, basic EPS at US$0.67 and trailing twelve month EPS at US$2.36, set against a very large 373.9% reported earnings growth over the past year. Over the last six reported quarters, revenue has ranged from US$43.5 million in Q4 2024 to US$112.9 million in Q4 2025, while quarterly EPS has...

ARMOUR Residential REIT (ARR) opened its latest earnings season update with investors focused on how its recent results line up with a year of shifting quarterly EPS and revenue, including Q4 2025 revenue of about US$225.7 million and EPS of US$1.86. Over the past six reported quarters, revenue has ranged from a loss of US$61.3 million in Q2 2025 to US$225.7 million in Q4 2025, while EPS has swung between a loss of US$0.94 and a gain of US$1.86. This sets up this quarter’s release as a check...

Wondering whether COMPASS Pathways at around US$9.15 still stacks up on value or has run ahead of itself? This article breaks down what the recent moves might mean for you as an investor. The stock has recently shown strong momentum, with returns of 37.4% over 7 days, 75.3% over 30 days, 39.7% year to date and 129.3% over 1 year, while the 3 year return sits at 13.2% and the 5 year return at a loss of 76.5%. These swings have come as COMPASS Pathways continues to sit in the spotlight of...

If you are wondering whether Ardelyx at around US$5.96 is priced attractively or not, the key question is how that tag compares with what the business might reasonably be worth. The stock has been volatile recently, with a 5.1% decline over the last 7 days, an 11.4% gain over 30 days, a 3.1% decline year to date, and an 18.7% return over the past year, which may signal changing views on its potential and risk. Recent headlines around Ardelyx have focused on its place in the biotech space and...

Stock Yards Bancorp (SYBT) has just wrapped up Q4 2025 with total revenue of US$102.7 million and basic EPS of US$1.25, setting the stage for its Q1 2026 reporting season with a trailing twelve month EPS of US$4.77. Over the last six reported quarters, total revenue has moved from US$85.5 million in Q3 2024 to US$102.7 million in Q4 2025, while basic EPS has shifted from US$1.00 to US$1.25. This gives investors a clearer line of sight on how earnings power is tracking into the new year. With...

If you are wondering whether ESAB at around US$102.92 is offering value or risk at this point, the recent mix of returns gives a useful starting point. Over the past week and month, the stock has returned 4.0% and 7.8% respectively, while year to date it is down 8.6%. The 1 year return shows a 13.9% decline, compared with an 80.7% gain over 3 years. Recent coverage has focused on ESAB's share price performance over different time frames and how that compares with the wider Machinery...

The United States market has remained flat over the past week but has experienced a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for sustained revenue expansion and innovation in a dynamic economic environment.

The United States market has remained flat over the past week, yet it has experienced a notable 30% rise over the last year, with earnings projected to grow by 16% annually in the coming years. In this context, identifying stocks that are potentially undervalued can offer investors opportunities to acquire shares at a discount relative to their intrinsic value.

Lam Research (LRCX) has put up another solid quarter, with Q3 2026 revenue at US$5.8b, basic EPS at US$1.46, and trailing twelve month EPS at US$5.32 as earnings over the last year grew 44.1%. The company has seen revenue move from US$4.7b in Q3 2025 to US$5.8b in Q3 2026, while quarterly basic EPS moved from US$1.04 to US$1.46 over the same period. This has set the stage for the 30.9% net margin reported over the last twelve months versus 27.2% in the prior year. Overall, these results point...

In the last week, the market has been flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% annually in the coming years. In this context, identifying stocks with strong financial health is crucial for investors looking to capitalize on growth opportunities. Although the term "penny stocks" might seem outdated, these shares often represent smaller or newer companies that can offer significant value and growth potential when backed by solid fundamentals.

Wondering if Core & Main at around US$48.95 is offering good value right now, or if the best part of the move is already behind it. The share price shows mixed recent returns, with a 7 day move of 5.8% decline, a 30 day return of 3.2% decline, year to date at 8.4% decline, but a 3 year gain of 87.8% that may still catch your eye. Recent coverage has focused on Core & Main's position in trade distribution and how investors are reassessing companies in this niche after shifts in market...

Range Resources (NYSE:RRC) reported a record-setting first quarter of 2026, with operational and financial results ahead of prior levels. The company posted its highest-ever natural gas and NGL premiums, alongside robust free cash flow and lower debt. Range Resources authorized a new $1.5 billion share repurchase program, expanding its shareholder return plan. Range Resources enters this update with its shares at $42.64 and a strong multi-year track record, including a 20.8% gain year to...

Pegasystems (NasdaqGS:PEGA) reported a weaker-than-expected Q1 2026, with revenue and profit declining year on year. The company cited macroeconomic pressures, geopolitical tensions, and shifting client behaviors as key headwinds. Pega Cloud and AI-driven Blueprint solutions continued to gain traction, even as overall results softened. Management is emphasizing new customer acquisition and cloud adoption, with an outlook for 2026 that is more heavily weighted toward the latter part of the...

If you are wondering whether Clean Harbors at around US$310 per share is still reasonably priced, the starting point is to understand how its current market value lines up with the underlying business. The stock has posted returns of 4.6% over the last 7 days, 8.8% over the past month, 27.5% year to date, 46.4% over 1 year, 115.1% over 3 years and 245.2% over 5 years. This naturally raises questions about how expectations and risk are being priced in today. Recent headlines have focused on...

Why Amicus Therapeutics is on investors’ radar today Amicus Therapeutics (FOLD) has caught investor attention after recent performance data showed modest positive returns over the past month and past 3 months, prompting closer focus on how its rare disease portfolio supports the current valuation. See our latest analysis for Amicus Therapeutics. At a share price of $14.46, Amicus Therapeutics shows only modest short term share price returns. The 1 year total shareholder return of 100.83%...

Wondering if Choice Hotels International at around US$120 is offering good value today or if the easy money has already been made? This article walks through what the current price might actually be saying. The stock has recently shown mixed performance, with a 1.7% return over the last 7 days, 21.2% over 30 days and 24.9% year to date, set against a 3.9% decline over the past year and a 9.2% return over five years. Recent coverage has focused on how Choice Hotels International fits into the...

If you are wondering whether Annaly Capital Management's share price still reflects fair value after a strong run, this article walks through what the current numbers may be saying about the stock. The stock last closed at US$22.43, with returns of 1.3% over 7 days, 6.4% over 30 days, a 2.1% decline year to date, 35.7% over 1 year, 70.0% over 3 years and 21.4% over 5 years. Recent coverage has focused on Annaly Capital Management's position within the mortgage REIT space and how interest...

Western Alliance Bancorporation (NYSE:WAL) addressed two significant fraud-related loan charge-offs in Q1 2026, which management believes helps clear legacy credit risk. The bank reported $5.6b in Q1 deposit growth and plans to shift from aggressive deposit gathering to a more balanced growth approach. These moves are intended to refine Western Alliance's risk management and funding profile following a period of strong deposit inflows. Western Alliance Bancorporation enters this shift with...

Investors may be wondering whether Cytokinetics at around US$65.48 is still offering value, or if most of the upside is already reflected in the price. The stock has returned 0.1% over the last week, 9.1% over the past 30 days, 6.1% year to date and 62.4% over the last year, with longer term returns of 73.0% over 3 years and 148.1% over 5 years. Recent coverage has focused on Cytokinetics as a biotech name that investors are watching closely, with attention on how its pipeline and...

Corpay Cross-Border, part of NYSE:CPAY, has entered a new partnership with Toulouse Football Club as the club's Official FX Supplier. The agreement extends Corpay's reach in European football, following its previously announced relationship with AC Milan. The deal focuses on supporting Toulouse FC's international payment and currency risk management needs. For readers tracking NYSE:CPAY, this Toulouse FC partnership adds another high profile sports relationship to Corpay's cross border...